MedTrace Logo

Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage

NCT02275949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-08-08

No results posted yet for this study

Summary

This study will evaluate acupuncture's effect of preventing vasospasm after SAH.

A total of 80 participants will be recruited and will be randomized to a study group or a control group. Acupuncture, electroacupuncture and intradermal acupuncture will be done at every session in a study group, while mock transcutaneous electrical nerve stimulation(mock TENS) and sham intradermal acupuncture will be carried out in a control group.

Conditions

  • SAH (Subarachnoid Hemorrhage)
  • Cerebral Vasospasm

Interventions

DEVICE

acupuncture

Acupuncture needles are inserted at the acupoints Zusanli(ST 36), Neiguan(PC 6), Gongsun(SP 4), and Xiangu(ST 43) bilaterally.

DEVICE

Electroacupuncture

The electric stimulator will be connected to the handles of each needles on the ST 36 and PC 6 bilaterally with 5Hz.

DEVICE

Intradermal acupuncture

Intradermal acupuncture needles with tape are inserted on the ST36, PC6, SP4, ST43 bilaterally and maintained until the next session.

DEVICE

Mock transcutaneous electrical nerve stimulation

Electrical insulator are attached on the ST36 and PC6 bilaterally, the same electric stimulator will be connected on the points with the same parameters as the study group, but without current intensity.

DEVICE

sham intradermal acupuncture

Intradermal acupuncture needles are put over the tape not penetrating the skin.

Sponsors & Collaborators

  • Kyung Hee University Hospital at Gangdong

    lead OTHER

Principal Investigators

  • Seong-Uk Park, KMD, PhD · Stroke & Neurological Disorders Center, Kyung Hee University Hospital at Gangdong

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275949 on ClinicalTrials.gov